Clinical trial Recruiting at 1 site Interventional Ages 0 Days to 1 Day

Supraglottic airway to support breathing in premature infants born at 29–33 weeks

Official title: Supraglottic Airway Interface for Positive Pressure Ventilation During Delivery Room Resuscitation of Premature Infants: A Pilot Feasibility Trial

Run by University of Pennsylvania · NCT07419438 · Data updated 2026-11-12

We will try using a supraglottic airway to give positive-pressure breaths right after birth to premature infants born at 29 0/7–33 6/7 weeks who need help breathing.

More Respiratory Failure trials

Quick facts

Study typeInterventional
Ages0 Days to 1 Day
SexAll
Enrollment20 (estimated)
SponsorUniversity of Pennsylvania
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedMarch 13, 2026
Main results expectedFebruary 2027
Study endsFebruary 2027
Registry record updatedNovember 10, 2026
Trial IDNCT07419438 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Premature infants born at 29 0/7 to 33 6/7 weeks' gestation with estimated birth weight ≥1000 g whose care team decides PPV is needed at birth and whose parent provided prenatal consent.

Probably not a fit

Extremely preterm infants (<29 weeks), babies with major congenital anomalies or aneuploidy, infants planned for palliative care, or those not resuscitated in the designated resuscitation room are unlikely to receive benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-arm feasibility trial will enroll infants born at 29 0/7 to 33 6/7 weeks' gestation who require positive-pressure ventilation (PPV) at delivery. Prenatal consent will be obtained and eligibility will be reconfirmed at the time of delivery. If resuscitation is required, a supraglottic airway (SA) will be used as the primary interface for PPV and clinical and procedural data will be collected during delivery-room resuscitation. The goal is to determine whether using an SA is practical and can provide effective ventilation in this preterm population.

Why it matters

Potential benefit: If successful, this approach could make initial breathing support easier and faster for moderate preterm infants and reduce the need for emergency intubation.

How similar studies have gone: Supraglottic airways have shown promise in term newborns and simulation studies, but routine use specifically for resuscitation of 29–33 week preterm infants is largely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Gestational age 29 0/7 to 33 6/7 weeks at birth
* Estimated fetal weight \>/= 1000 grams at birth
* Clinical decision to initiate PPV
* Parental informed consent

Exclusion Criteria:

* Major anomalies or aneuploidy
* Palliative care planned or considered
* Not resuscitated in the infant resuscitation room

Where it's running

  • Hospital of the University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.